Cubist Systematic Strategies’s Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50 MNTN.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding MNTN.WS
Cubist Systematic Strategies's MNTN.WS Position: Q4 2024 in Review
Cubist Systematic Strategies sold out of Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50 (MNTN.WS) in Q4 2024, closing a stake of 42,564 shares — an estimated $1.26K sold.
Cubist Systematic Strategies first reported a position in MNTN.WS in Q1 2022 and held it in 11 quarters. The position peaked at $73K in Q1 2022. 5 funds tracked by Wall St. Rank hold MNTN.WS as of Q4 2024.
- Cubist Systematic Strategies reported no remaining Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50 position as of Q4 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 42,564 Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50 shares in Q4 2024, an estimated $1.26K.
- Cubist Systematic Strategies first reported a position in Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50 in Q1 2022 and held it in 11 quarters.
- Cubist Systematic Strategies's Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50 position peaked at $73K in Q1 2022.
- 5 funds tracked by Wall St. Rank held Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50 as of Q4 2024.
Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.